What is Formoflo 125 mcg Transhaler

Formoflo 125 mcg Transhaler is a combination dry powder inhaler containing FDA-approved Formoterol (6 mcg) and Fluticasone Propionate (125 mcg) as its active ingredients. It is prescribed for the long-term maintenance treatment of Asthma and Chronic Obstructive Pulmonary Disease (COPD) in adults and adolescents. Lupin Ltd manufactures Formoflo 125 mcg Transhaler in GMP-compliant facilities under strict quality standards.

Formoterol is a Long-acting Beta-2 Adrenergic Agonist (LABA), which works by relaxing the airway muscles, helping to keep the airways open and making breathing easier. It has a rapid onset of action within 1 to 3 minutes and provides long-lasting bronchodilation for up to 12 hours, making it suitable for twice-daily use. This helps prevent symptoms such as wheezing, breathlessness, and airway narrowing.

Fluticasone Propionate is an inhaled corticosteroid (ICS), which works by reducing inflammation in the airways. It suppresses the release of inflammatory substances, helping reduce swelling, mucus production, and airway sensitivity over time. This addresses the underlying cause of persistent symptoms and reduces the risk of flare-ups.

The Transhaler is a breath-actuated dry powder inhaler, meaning the medication is released automatically during inhalation without the need for manual coordination. Some of the common side effects of Formoflo Transhaler include throat irritation, hoarseness, oral thrush, headache, palpitations, and tremors.

Before starting treatment, inform a doctor about any history of cardiovascular disease, Hypertension, Diabetes, Thyroid disorders, or known allergies to the ingredients, as these may affect suitability and monitoring. Store the Transhaler in a dry place below 30°C, away from moisture and sunlight, and keep the cap closed when not in use.

What are the benefits of using Formoflo 125 mcg Transhaler

Formoflo 125 Transhaler provides clinically significant benefits for patients requiring consistent long-term control of obstructive airway conditions. Some of them include:

• Rapid and long-acting bronchodilation: Formoterol's fast onset and 12-hour duration of action prevent recurring Bronchospasm and breathlessness throughout the day and night, supporting reliable twice-daily maintenance dosing.
• Sustained airway inflammation control: Fluticasone Propionate suppresses the chronic inflammatory processes driving mucosal swelling, mucus overproduction, and bronchial hypersensitivity, reducing worsening of symptoms and supporting improved long-term lung function.
• Dual-action maintenance therapy: The combination of a LABA and an ICS in one device addresses both Asthma and COPD more effectively.
• Breath-actuated Transhaler device: The device delivers medication automatically during inhalation, eliminating the coordination barrier of pressurized Metered-dose Inhalers (MDIs) and ensuring more consistent, effective medicine delivery with each dose.
• Reduced rescue inhaler dependence: With consistent use, Formoflo 125 mcg Transhaler reduces the frequency of acute symptoms and the need for short-acting rescue bronchodilators, reflecting improved overall airway control.

How to use Formoflo 125 mcg Transhaler

Formoflo 125 mcg Transhaler is a prescription medication that must be used as directed by a healthcare professional. Here are the general guidelines:

• Inhale a dose twice daily, in the morning and evening, at approximately the same times each day, or as directed by a doctor.
• Open the cap, breathe out gently away from the device, place the mouthpiece between the teeth without biting, seal the lips around it, and inhale deeply and steadily. The device will release the dose automatically during inhalation. Hold the breath for nearly 10 seconds before exhaling slowly.
• Rinse the mouth with water and spit it out after every use to reduce the risk of oral thrush from Fluticasone Propionate. Do not swallow the rinse water.
• Do not exceed the prescribed dosage. Formoflo 125 mcg Transhaler is a maintenance inhaler and must not be used as a rescue inhaler for sudden breathing attacks.

Strengths and Substitutes

Formoflo Transhaler is currently available in a single strength option at Cheap Medicine Shop. However, you can consider the following alternatives:

View all substitutes

What are the side effects of Formoflo 125 mcg Transhaler

Like any medication, Formoflo 125 mcg Transhaler can cause some side effects. However, they are generally mild and subside as the body adjusts to treatment. Some of them include:

• Throat irritation or hoarseness
• Oral thrush
• Headache
• Palpitations or increased heart rate
• Tremors
• Coughing after inhalation
• Nausea

If these effects worsen with time or persist, seek medical guidance immediately.

Safety Advice

Liver Disease

Formoflo Transhaler should be used with caution in patients with liver disease. Impaired liver function may reduce the clearance of Fluticasone Propionate, leading to increased systemic corticosteroid exposure and a higher risk of side effects. Although the risk is minimal in inhaled medicines, always inform a doctor of any liver conditions before initiating treatment.

Kidney Impairment

The Transhaler should be used with caution in patients with kidney disease. While inhaled delivery limits systemic absorption, the cardiovascular effects of Formoterol and the potential for Hypokalemia (low potassium levels) with beta-2 agonist use require evaluation. Inform a doctor of any kidney conditions before starting this medication.

Pregnant and Breastfeeding women

Formoflo 125 mcg Transhaler should not be used during pregnancy as it can harm the baby. Both Formoterol and Fluticasone Propionate can pass into breast milk. So, breastfeeding should be stopped during treatment, unless a doctor confirms safety.

Avoid

Do not use Formoflo 125 mcg Transhaler as a rescue medication for acute Bronchospasm. Avoid in patients with known hypersensitivity to Formoterol, Fluticasone Propionate, or any component of the inhaler. Do not use concurrently with other long-acting beta agonists. Inform a doctor of all current medications, particularly beta-blockers, which can oppose the bronchodilatory effect of Formoterol, and diuretics or other medications affecting potassium levels.